Atlas Trials

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

Clinical trial NCT06994572 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06994572
Sponsor
Captor Therapeutics S.A.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma (HCC)
Start date
2025-05-26
Primary completion
2029-04-16
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.